Thyroid disorders in pregnancy

Endocrinology and Metabolism Clinics of North America

Volumn 40, Issue 4, 2011, Pages 739-763

  Krajewski, Dorota A ^a   Burman, Kenneth D ^a,b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Fetal neurodevelopment; Gestational thyrotoxicosis; Graves' disease; Maternal hypothyroidism; Postpartum thyroiditis; Pregnancy; Thyroid cancer; Thyroid dysfunction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; IODINE; LEVOTHYROXINE; LIOTHYRONINE; PLACEBO; PROPYLTHIOURACIL; RADIOACTIVE IODINE; SELENIUM; THIAMAZOLE; THIONAMIDE; THYROID ANTIBODY; THYROTROPIN; THYROXINE; THYROXINE BINDING GLOBULIN; THYROXINE DEIODINASE;

AMINOTRANSFERASE BLOOD LEVEL; ASPIRATION BIOPSY; BREAST FEEDING; CESAREAN SECTION; CHILDBIRTH; CHOANA ATRESIA; CHOLESTASIS; COGNITIVE DEFECT; CONGENITAL HYPOTHYROIDISM; CONGESTIVE HEART FAILURE; DIFFERENTIAL DIAGNOSIS; DRUG CONTRAINDICATION; ECHOGRAPHY; FETUS DEATH; FETUS DEVELOPMENT; FETUS ECHOGRAPHY; GESTATION PERIOD; GOITER; GRAVES DISEASE; HEART OUTFLOW TRACT OBSTRUCTION; HORMONE DETERMINATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IODINE DEFICIENCY; KIDNEY AGENESIS; LIVER FAILURE; LOW BIRTH WEIGHT; MATERNAL HYPERTENSION; MENTAL DEFICIENCY; PATIENT MONITORING; POSTPARTUM HEMORRHAGE; POSTPARTUM THYROIDITIS; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAFETY; SIDE EFFECT; SITUS INVERSUS; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; SUBTOTAL THYROIDECTOMY; THYROID CANCER; THYROID CARCINOMA; THYROID FUNCTION; THYROID FUNCTION TEST; THYROID NODULE; THYROIDECTOMY; THYROIDITIS; THYROTOXICOSIS;

ADOLESCENT; ADULT; FEMALE; FETAL DEVELOPMENT; FETAL DISEASES; GESTATIONAL AGE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; INFANT, NEWBORN; IODINE; IODINE RADIOISOTOPES; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PUERPERAL DISORDERS; THYROID DISEASES; THYROID GLAND; THYROID HORMONES; THYROID NEOPLASMS; THYROID NODULE;

EID: 82855166082     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2011.08.004     Document Type: Review

References (132)

1. Williams G.R. Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol 2008, 20(6):784-794.
2. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997, 18(3):404-433.
3. Burrow G.N., Fisher D.A., Larsen P.R. Maternal and fetal thyroid function. N Engl J Med 1994, 331(16):1072-1078.
4. Celi F. Thyroid physiology and drugs affecting thyroid function. Paper presented at: A Review of Endocrinology: Diagnosis & Treatment. Bethesda (MD), October 12, 2010.
5. Calvo R.M., Jauniaux E., Gulbis B., et al. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 2002, 87(4):1768-1777.
6. Burman K.D., Read J., Dimond R.C., et al. Measurement of 3,3',5'-triiodothyroinine (reverse T3), 3,3'-L-diiodothyronine, T3 and T4 in human amniotic fluid and in cord and maternal serum. J Clin Endocrinol Metab 1976, 43(6):1351-1359.
7. Contempre B., Jauniaux E., Calvo R., et al. Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab 1993, 77(6):1719-1722.
8. Vulsma T., Gons M.H., de Vijlder J.J. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 1989, 321(1):13-16.
9. Yassa L., Marqusee E., Fawcett R., et al. Thyroid Hormone Early Adjustment in Pregnancy (the THERAPY) trial. J Clin Endocrinol Metab 2010, 95:3234-3241.
10. Alexander E.K., Marqusee E., Lawrence J., et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004, 351(3):241-249.
11. Auso E., Lavado-Autric R., Cuevas E., et al. A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 2004, 145(9):4037-4047.
12. 2+/calmodulin-dependent protein kinase IV pathway. Endocrinology 2010, 151(2):810-820.
13. Liu D., Teng W., Shan Z., et al. The effect of maternal subclinical hypothyroidism during pregnancy on brain development in rat offspring. Thyroid 2010, 20(8):909-915.
14. Ahmed O.M., Abd El-Tawab S.M., Ahmed R.G. Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: I. The development of the thyroid hormones-neurotransmitters and adenosinergic system interactions. Int J Dev Neurosci 2010, 28(6):437-454.
15. Sinha R.A., Pathak A., Kumar A., et al. Enhanced neuronal loss under perinatal hypothyroidism involves impaired neurotrophic signaling and increased proteolysis of p75(NTR). Mol Cell Neurosci 2009, 40(3):354-364.
16. Fisher D.A., Klein A.H. Thyroid development and disorders of thyroid function in the newborn. N Engl J Med 1981, 304(12):702-712.
17. Pop V.J., Brouwers E.P., Vader H.L., et al. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf) 2003, 59(3):282-288.
18. Li Y., Shan Z., Teng W., et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin Endocrinol (Oxf) 2010, 72(6):825-829.
19. Aoki Y., Belin R.M., Clickner R., et al. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid 2007, 17(12):1211-1223.
20. Klein R.Z., Haddow J.E., Faix J.D., et al. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) 1991, 35(1):41-46.
21. Vaidya B., Anthony S., Bilous M., et al. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding?. J Clin Endocrinol Metab 2007, 92(1):203-207.
22. Moleti M., Lo Presti V.P., Mattina F., et al. Gestational thyroid function abnormalities in conditions of mild iodine deficiency: early screening versus continuous monitoring of maternal thyroid status. Eur J Endocrinol 2009, 160(4):611-617.
23. Stagnaro-Green A., Roman S.H., Cobin R.H., et al. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990, 264(11):1422-1425.
24. Negro R., Formoso G., Mangieri T., et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006, 91(7):2587-2591.
25. Glinoer D., Riahi M., Grun J.P., et al. Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab 1994, 79(1):197-204.
26. Mannisto T., Vaarasmaki M., Pouta A., et al. Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J Clin Endocrinol Metab 2010, 95(3):1084-1094.
27. Allan W.C., Haddow J.E., Palomaki G.E., et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 2000, 7(3):127-130.
28. Casey B.M., Dashe J.S., Wells C.E., et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005, 105(2):239-245.
29. Negro R., Schwartz A., Gismondi R., et al. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab 2010, 95(9):E44-E48.
30. Haddow J.E., Palomaki G.E., Allan W.C., et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999, 341(8):549-555.
31. Alvarez-Pedrerol M., Guxens M., Mendez M., et al. Iodine levels and thyroid hormones in healthy pregnant women and birth weight of their offspring. Eur J Endocrinol 2009, 160(3):423-429.
32. de Escobar G.M., Obregon M.J., del Rey F.E. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 2004, 18(2):225-248.
33. Andersson M., de Benoist B., Delange F., et al. Prevention and control of iodine deficiency in pregnant and lactating women and in children less than 2-years-old: conclusions and recommendations of the Technical Consultation. Public Health Nutr 2007, 10(12A):1606-1611.
34. Becker D.V., Braverman L.E., Delange F., et al. Iodine supplementation for pregnancy and lactation-United States and Canada: recommendations of the American Thyroid Association. Thyroid 2006, 16(10):949-951.
35. Surks M.I., Ortiz E., Daniels G.H., et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004, 291(2):228-238.
36. Abalovich M., Amino N., Barbour L.A., et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007, 92(Suppl 8):S1-S47.
37. Negro R., Schwartz A., Gismondi R., et al. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 2010, 95(4):1699-1707.
38. Lazarus J. Pregnancy and thyroid diseases. Paper presented at: The 14th International Thyroid Congress. Paris, September 11-16, 2010.
39. Roti E., Gardini E., Minelli R., et al. Thyroid function evaluation by different commercially available free thyroid hormone measurement kits in term pregnant women and their newborns. J Endocrinol Invest 1991, 14(1):1-9.
40. Baloch Z., Carayon P., Conte-Devolx B., et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003, 13(1):3-126.
41. Mandel S.J., Spencer C.A., Hollowell J.G. Are detection and treatment of thyroid insufficiency in pregnancy feasible?. Thyroid 2005, 15(1):44-53.
42. Glinoer D., Spencer C.A. Serum TSH determinations in pregnancy: how, when and why?. Nat Rev Endocrinol 2010, 6(9):526-529.
43. Loh J.A., Wartofsky L., Jonklaas J., et al. The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism. Thyroid 2009, 19(3):269-275.
44. Lazarus J.H., Premawardhana L.D. Screening for thyroid disease in pregnancy. J Clin Pathol 2005, 58(5):449-452.
45. Innerfield F., Hollander C.S. Thyroidal complications of pregnancy. Med Clin North Am 1977, 61(1):67-87.
46. Tamaki H., Itoh E., Kaneda T., et al. Crucial role of serum human chorionic gonadotropin for the aggravation of thyrotoxicosis in early pregnancy in Graves' disease. Thyroid 1993, 3(3):189-193.
47. Rotondi M., Cappelli C., Pirali B., et al. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab 2008, 93(10):3985-3988.
48. Glinoer D. The thyroid in pregnancy: the European perspective. Thyroid Today 1995, 18:1-11.
49. Kosugi S., Mori T. TSH receptor and LH receptor, 1995. Endocr J 1995, 42(5):587-606.
50. Tsuruta E., Tada H., Tamaki H., et al. Pathogenic role of asialo human chorionic gonadotropin in gestational thyrotoxicosis. J Clin Endocrinol Metab 1995, 80(2):350-355.
51. Monson K, Schoenstadt A. Beta blockers and pregnancy. eMedTV. Available at: Accessed October 31, 2010. http://senior-health.emedtv.com/beta-blockers/beta-blockers-and-pregnancy.html.
52. Davis R.L., Eastman D., McPhillips H., et al. Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf 2011, 20(2):138-145.
53. Hershman J.M. Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors. Thyroid 1999, 9(7):653-657.
54. Goodwin T.M., Montoro M., Mestman J.H., et al. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 1992, 75(5):1333-1337.
55. Luewan S., Chakkabut P., Tongsong T. Outcomes of pregnancy complicated with hyperthyroidism: a cohort study. Arch Gynecol Obstet 2011, 283(2):243-247.
56. Davis L.E., Lucas M.J., Hankins G.D., et al. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 1989, 160(1):63-70.
57. Pillar N., Levy A., Holcberg G., et al. Pregnancy and perinatal outcome in women with hyperthyroidism. Int J Gynaecol Obstet 2010, 108(1):61-64.
58. Donovan L., Parkins V.M., Mahalingham A. Thyrotoxic periodic paralysis in pregnancy with impaired glucose tolerance: a case report and discussion of management issues. Thyroid 2007, 17(6):579-583.
59. Anselmo J., Cao D., Karrison T., et al. Fetal loss associated with excess thyroid hormone exposure. JAMA 2004, 292(6):691-695.
60. Bánhidy F., Puhó E.H., Czeizel A.E. Possible association between hyperthyroidism in pregnant women and obstructive congenital abnormalities of urinary tract in their offspring-a population-based case-control study. J Matern Fetal Neonatal Med 2011, 24(2):305-312.
61. Casey B.M., Dashe J.S., Wells C.E., et al. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006, 107(2 Pt 1):337-341.
62. Evans I.M., Pickard M.R., Sinha A.K., et al. Influence of maternal hyperthyroidism in the rat on the expression of neuronal and astrocytic cytoskeletal proteins in fetal brain. J Endocrinol 2002, 175(3):597-604.
63. Chen C., Zhou Z., Zhong M., et al. Excess thyroid hormone inhibits embryonic neural stem/progenitor cells proliferation and maintenance through STAT3 signalling pathway. Neurotox Res 2011, 20(1):15-25.
64. Tran P., Desimone S., Barrett M., et al. I-131 treatment of graves' disease in an unsuspected first trimester pregnancy; the potential for adverse effects on the fetus and a review of the current guidelines for pregnancy screening. Int J Pediatr Endocrinol 2010, 2010:858359.
65. Berg G., Jacobsson L., Nystrom E., et al. Consequences of inadvertent radioiodine treatment of Graves' disease and thyroid cancer in undiagnosed pregnancy. Can we rely on routine pregnancy testing?. Acta Oncol 2008, 47(1):145-149.
66. 131I therapy for hyperthyroidism in the first trimester of pregnancy. J Nucl Med 1976, 17(02):146-149.
67. Hatch M., Brenner A., Bogdanova T., et al. A screening study of thyroid cancer and other thyroid diseases among individuals exposed in utero to iodine-131 from Chernobyl fallout. J Clin Endocrinol Metab 2009, 94(3):899-906.
68. Practice guideline for the performance of therapy with unsealed radiopharmaceutical sources 2010, ACR, Available at:, Accessed October 31, 2010. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines/nuc_med/unsealed_radiopharmaceuticals.aspx.
69. Basbug M., Ozgun M.T., Murat N., et al. Prenatal diagnosis of fetal hypothyroidism after maternal radioactive iodine exposure during pregnancy. J Clin Ultrasound 2010, 38(9):506-508.
70. Gardner D.F., Cruikshank D.P., Hays P.M., et al. Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests. J Clin Endocrinol Metab 1986, 62(1):217-220.
71. Mortimer R.H., Cannell G.R., Addison R.S., et al. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 1997, 82(9):3099-3102.
72. Cooper D.S. Antithyroid drugs. N Engl J Med 2005, 352(9):905-917.
73. Cooper D.S., Rivkees S.A. Putting propylthiouracil in perspective. J Clin Endocrinol Metab 2009, 94(6):1881-1882.
74. Rivkees S.A., Mattison D.R. Propylthiouracil (PTU) hepatotoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol 2009, 2009:132041.
75. Russo M.W., Galanko J.A., Shrestha R., et al. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004, 10(8):1018-1023.
76. Burch HS. ATA-AACE Hyperthyroidism guidelines 2010. A review of endocrinology: diagnosis & treatment. Lecture at the Endocrinology Board Review Course. FAES (The Foundation for Advanced Education in the Sciences, Inc. at the National Institutes of Health and The George Washington University Medical Center). Bethesda (MD), October 12, 2010.
77. Barbero P., Valdez R., Rodriguez H., et al. Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am J Med Genet A 2008, 146(18):2390-2395.
78. Clementi M., Di Gianantonio E., Cassina M., et al. Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab 2010, 95(11):E337-E341.
79. Mandel S.J., Brent G.A., Larsen P.R. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid 1994, 4(1):129-133.
80. Kempers M.J., van Trotsenburg A.S., van Rijn R.R., et al. Loss of integrity of thyroid morphology and function in children born to mothers with inadequately treated Graves' disease. J Clin Endocrinol Metab 2007, 92(8):2984-2991.
81. Papendieck P., Chiesa A., Prieto L., et al. Thyroid disorders of neonates born to mothers with graves' disease. J Pediatr Endocrinol Metab 2009, 22(6):547-553.
82. Rosenfeld H., Ornoy A., Shechtman S., et al. Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study. Br J Clin Pharmacol 2009, 68(4):609-617.
83. Momotani N., Noh J.Y., Ishikawa N., et al. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab 1997, 82(11):3633-3636.
84. Gruner C., Kollert A., Wildt L., et al. Intrauterine treatment of fetal goitrous hypothyroidism controlled by determination of thyroid-stimulating hormone in fetal serum. A case report and review of the literature. Fetal Diagn Ther 2001, 16(1):47-51.
85. Luton D., Le Gac I., Vuillard E., et al. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 2005, 90(11):6093-6098.
86. McKenzie J.M., Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 1992, 2(2):155-159.
87. Connors M.H., Styne D.M. Transient neonatal 'athyreosis' resulting from thyrotropin-binding inhibitory immunoglobulins. Pediatrics 1986, 78(2):287-290.
88. Eisenstein Z., Weiss M., Katz Y., et al. Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero. Eur J Pediatr 1992, 151(8):558-559.
89. Laurberg P., Bournaud C., Karmisholt J., et al. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 2009, 160(1):1-8.
90. Laurberg P., Nygaard B., Glinoer D., et al. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 1998, 139(6):584-586.
91. Zakarija M., McKenzie J.M., Munro D.S. Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease. J Clin Invest 1983, 72(4):1352-1356.
92. Momotani N., Noh J., Oyanagi H., et al. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med 1986, 315(1):24-28.
93. Bahn R.S., Burch H.S., Cooper D.S., et al. The Role of propylthiouracil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 2009, 19(7):673-674.
94. Laurberg P., Wallin G., Tallstedt L., et al. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol 2008, 158(1):69-75.
95. Mandel S.J., Cooper D.S. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 2001, 86(6):2354-2359.
96. Kampmann J.P., Johansen K., Hansen J.M., et al. Propylthiouracil in human milk. Revision of a dogma. Lancet 1980, 1(8171):736-737.
97. Johansen K., Andersen A.N., Kampmann J.P., et al. Excretion of methimazole in human milk. Eur J Clin Pharmacol 1982, 23(4):339-341.
98. Azizi F., Khoshniat M., Bahrainian M., et al. Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab 2000, 85(9):3233-3238.
99. Momotani N., Yamashita R., Makino F., et al. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil. Clin Endocrinol (Oxf) 2000, 53(2):177-181.
100. Roti E., Uberti E. Post-partum thyroiditis-a clinical update. Eur J Endocrinol 2002, 146(3):275-279.
101. Kokandi A.A., Parkes A.B., Premawardhana L.D., et al. Association of postpartum thyroid dysfunction with antepartum hormonal and immunological changes. J Clin Endocrinol Metab 2003, 88(3):1126-1132.
102. Negro R., Greco G., Mangieri T., et al. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007, 92(4):1263-1268.
103. Premawardhana L.D., Parkes A.B., Ammari F., et al. Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. J Clin Endocrinol Metab 2000, 85(1):71-75.
104. Lazarus J.H., Ammari F., Oretti R., et al. Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract 1997, 47(418):305-308.
105. Manetti L., Parkes A.B., Lupi I., et al. Serum pituitary antibodies in normal pregnancy and in patients with postpartum thyroiditis: a nested case-control study. Eur J Endocrinol 2008, 159(6):805-809.
106. Weetman A.P. Insulin-dependent diabetes mellitus and postpartum thyroiditis: an important association. J Clin Endocrinol Metab 1994, 79(1):7-9.
107. Kuijpens J.L., Vader H.L., Drexhage H.A., et al. Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum. Eur J Endocrinol 2001, 145(5):579-584.
108. Singer P.A., Cooper D.S., Daniels G.H., et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 1996, 156(19):2165-2172.
109. Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med 2004, 351(17):1764-1771.
110. Gharib H., Papini E., Paschke R., et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2010, 16(Suppl 1):1-43.
111. Kung A.W., Chau M.T., Lao T.T., et al. The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metab 2002, 87(3):1010-1014.
112. Papini E., Guglielmi R., Bianchini A., et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002, 87(5):1941-1946.
113. Burch H.B. Evaluation and management of the solid thyroid nodule. Endocrinol Metab Clin North Am 1995, 24(4):663-710.
114. Cooper D.S., Doherty G.M., Haugen B.R., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006, 16(2):109-142.
115. Cooper D.S., Doherty G.M., Haugen B.R., et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19(11):1167-1214.
116. Cobin R.H., Gharib H., Bergman D.A., et al. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 2001, 7(3):202-220.
117. Gharib H., Goellner J.R., Zinsmeister A.R., et al. Fine-needle aspiration biopsy of the thyroid. The problem of suspicious cytologic findings. Ann Intern Med 1984, 101(1):25-28.
118. Castro M.R., Caraballo P.J., Morris J.C. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 2002, 87(9):4154-4159.
119. Papini E., Petrucci L., Guglielmi R., et al. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 1998, 83(3):780-783.
120. Uzzan B., Campos J., Cucherat M., et al. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 1996, 81(12):4278-4289.
121. Donegan W.L. Cancer and pregnancy. CA Cancer J Clin 1983, 33(4):194-214.
122. Moosa M., Mazzaferri E.L. Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab 1997, 82(9):2862-2866.
123. Zamperini P., Gibelli B., Gilardi D., et al. Pregnancy and thyroid cancer: ultrasound study of foetal thyroid. Acta Otorhinolaryngol Ital 2009, 29(6):339-344.
124. Vini L., Hyer S., Pratt B., et al. Management of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol 1999, 140(5):404-406.
125. Rosen I.B., Walfish P.G. Pregnancy as a predisposing factor in thyroid neoplasia. Arch Surg 1986, 121(11):1287-1290.
126. Galanti M.R., Lambe M., Ekbom A., et al. Parity and risk of thyroid cancer: a nested case-control study of a nationwide Swedish cohort. Cancer Causes Control 1995, 6(1):37-44.
127. Imai Y., Yamakawa M., Matsuda M., et al. Endogenous sex hormone and estrogen binding activity in thyroid cancer. Histol Histopathol 1989, 4(1):39-45.
128. Woolner L.B., Beahrs O.H., Black B.M., et al. Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a thirty year period. Am J Surg 1961, 102:354-387.
129. Mazzaferri E.L., Jhiang S.M. Differentiated thyroid cancer long-term impact of initial therapy. Trans Am Clin Climatol Assoc 1995, 106:151-168. [discussion: 168-70].
130. Kuy S., Roman S.A., Desai R., et al. Outcomes following thyroid and parathyroid surgery in pregnant women. Arch Surg 2009, 144(5):399-406. [discussion: 406].
131. Choe W., McDougall I.R. Thyroid cancer in pregnant women: diagnostic and therapeutic management. Thyroid 1994, 4(4):433-435.
132. Panesar N.S., Li C.Y., Rogers M.S. Reference intervals for thyroid hormones in pregnant Chinese women. Ann Clin Biochem 2001, 38(Pt 4):329-332.